X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/taiho-oncology-announces-publication-of-final-results-of-the-phase-3-ascertain-clinical-trial-of-oral-decitabine-and-cedazuridine-fixed-dose-combination-inqovi-in-patients-with-mds-and-cmml-302041085.html
https://www.prnewswire.com/news-releases/taiho-oncology-announces-presentation-of-data-from-a-us-real-word-study-of-oral-decitabine-and-cedazuridine-302010317.html
https://www.ema.europa.eu/en/documents/overview/inaqovi-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2023/06/05/2681819/0/en/Foghorn-Therapeutics-Announces-FDA-Has-Lifted-Clinical-Hold-on-Phase-1-Study-of-FHD-286-in-Relapsed-and-or-Refractory-AML-MDS-Patients.html
https://www.pharmatimes.com/news/ema_accepts_application_for_leukaemia_drug_from_otsuka_and_astex_1453762
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213472
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214486
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212959
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212826
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212117
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205539
https://www.prnewswire.com/news-releases/national-comprehensive-cancer-network-adds-inqovi-decitabine-and-cedazuridine-tablets-to-its-clinical-practice-guidelines-in-oncology-for-myelodysplastic-syndromes-301178152.html
https://www.fiercepharma.com/drug-delivery/astex-pharmaceuticals-nabs-green-light-for-oral-chemotherapy-inqovi
https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/inqovi-approved-myelodysplastic-syndromes-mds-de-novo-secondary-mds/
https://www.otsuka.co.jp/en/company/newsreleases/2020/20200708_1.html#:~:text=of%20their%20homes-,Otsuka%20Pharmaceutical%20Co.%2C%20Ltd.,leukemia)%2C%20two%20blood%20malignancies.
https://www.globenewswire.com/news-release/2021/04/05/2204178/0/en/Bio-Path-Holdings-Announces-Successful-Completion-of-Safety-Cohort-of-Triple-Combination-of-Prexigebersen-Decitabine-and-Venetoclax-in-Stage-2-of-Phase-2-Clinical-Trial-in-Acute-My.html
https://www.businesswire.com/news/home/20200211005230/en/Astex-Pharmaceuticals-Announces-U.S.-Food-Drug-Administration/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.thepharmaletter.com/in-brief/brief-msn-labs-to-launch-two-new-generics-in-usa
https://www.prnewswire.com/news-releases/novadoz-pharmaceuticalsmsn-labs-receives-fda-clearance-for-fosaprepitant-and-decitabine-the-companys-first-generic-specialty-injectable-products-300912919.html
https://endpts.com/otsuka-scores-phiii-win-for-another-astex-drug-gsk-expands-nucala-use-in-asthma/
https://www.moneycontrol.com/news/business/wockhardt-gets-usfda-nod-for-decitabine-injection-3802361.html
https://www.oncnet.com/news/decitabine-plus-chemo-denotes-new-induction-therapy-option-aml-mds-features
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210897
https://www.pharmacompass.com/pdf/news/jiangsu-yew-pharmaceutical-co-ltd-fails-edqm-inspection-1537438043.pdf
https://endpts.com/otsukas-886m-plus-drug-just-flopped-in-its-first-crucial-phiii-trial-for-frontline-aml/
http://www.pharmatimes.com/news/roches_venclexta_filed_in_the_us_for_acute_myeloid_leukemia_1244055
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-18-2018-1524029703.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208601
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206033
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204607
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203475
Market Place
Share 
